The use of neoadjuvant systemic therapy in the treatment of breast cancer patients is
increasing beyond the scope of locally advanced disease. Imaging provides important …

Breast imaging is largely indicated for detection, diagnosis, and clinical management of
breast cancer and for evaluation of the integrity of breast implants. In this work, a prospective …

Purpose: To compare changes in the concentration of choline-containing compounds (tCho)
and in tumor size at follow-up after neoadjuvant chemotherapy (NAC) between patients who …

Proton magnetic resonance spectroscopy (MRS) is a promising noninvasive diagnostic
technique for investigation of breast cancer metabolism. Spectroscopic imaging data may be …

Metabolic reprogramming is one of the hallmarks of cancer and includes the Warburg effect,
which is exhibited by many tumours. This can be exploited by positron emission tomography …

An emerging clinical modality called proton magnetic resonance spectroscopy (1 H-MRS)
enables the non-invasive in vivo assessment of tissue metabolism and is demonstrating …

Purpose To estimate the accuracy of predicting response to neoadjuvant chemotherapy
(NACT) in patients with locally advanced breast cancer using MR spectroscopy (MRS) …

Magnetic resonance (MR) spectroscopy is a noninvasive diagnostic modality that can
measure chemical information from a selected region in the body. MR imaging scanners are …

Purpose This study aimed to evaluate whether MR metabolic profiling can be used for
prediction of long‐term survival and monitoring of treatment response in locally advanced …

The aim of this study was to determine whether tumor size, MRS parameters and apparent
diffusion coefficient (ADC) measurements could be applied to predict pathologic complete …